PharMerica Co. (NYSE:PMC) CEO Gregory S. Weishar sold 521,089 shares of PharMerica stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $29.25, for a total transaction of $15,241,853.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of PharMerica Co. (NYSE PMC) traded up $0.05 during trading on Monday, reaching $29.25. 1,371,600 shares of the company’s stock were exchanged, compared to its average volume of 283,015. The company has a current ratio of 2.58, a quick ratio of 1.79 and a debt-to-equity ratio of 0.79. The stock has a market cap of $910.27, a P/E ratio of 15.15, a P/E/G ratio of 1.27 and a beta of 0.82. PharMerica Co. has a fifty-two week low of $22.00 and a fifty-two week high of $29.50.
PharMerica (NYSE:PMC) last issued its quarterly earnings data on Thursday, November 9th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.49 by ($0.03). The company had revenue of $595.10 million for the quarter, compared to analysts’ expectations of $596.80 million. PharMerica had a net margin of 0.83% and a return on equity of 10.94%. sell-side analysts expect that PharMerica Co. will post 1.92 EPS for the current fiscal year.
A number of institutional investors have recently modified their holdings of the business. California Public Employees Retirement System increased its position in PharMerica by 5.6% during the 3rd quarter. California Public Employees Retirement System now owns 97,587 shares of the company’s stock valued at $2,859,000 after purchasing an additional 5,187 shares during the period. Allianz Asset Management GmbH grew its position in shares of PharMerica by 3,347.4% in the 3rd quarter. Allianz Asset Management GmbH now owns 399,591 shares of the company’s stock worth $11,708,000 after buying an additional 388,000 shares during the period. Schwab Charles Investment Management Inc. grew its position in shares of PharMerica by 1.5% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 269,518 shares of the company’s stock worth $7,897,000 after buying an additional 3,864 shares during the period. WINTON GROUP Ltd purchased a new stake in shares of PharMerica in the 3rd quarter worth about $2,150,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of PharMerica in the 3rd quarter worth about $7,031,000. 89.97% of the stock is currently owned by institutional investors and hedge funds.
Receive News & Ratings for PharMerica Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharMerica Co. and related companies with MarketBeat.com's FREE daily email newsletter.